MedTrace Logo

Pulmonary Hypertension in Haemodialysis Patients :Frequency and Risk Factors

NCT03310229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-01-20

No results posted yet for this study

Summary

High mortality rates due to cardiovascular disease in end-stage renal disease patients been described by epidemiological and clinical studies. It accounts for approximately 50 percent of deaths in dialysis patients. Although controversial, this may be due to the presence of excess vascular calcification particularly in the form of extensive coronary artery calcification which can be observed even in very young dialysis patients. It was suggested that abnormalities of the right ventricular function in patients with end-stage renal disease were largely due to pulmonary hypertension which usually develops secondary to pulmonary artery calcifications.

Conditions

  • Pulmonary Hypertension

Interventions

RADIATION

plain chest x-ray

the participants will be subjected to plain chest x-ray with other tools to help diagnose pulmonary hypertension in haemodialysis patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed abbass · Assiut University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-12-01
Completion
2019-12-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310229 on ClinicalTrials.gov